KLP Kapitalforvaltning’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$96.5M Buy
1,591,658
+28,500
+2% +$1.66M 0.38% 42
2025
Q4
$84.3M Buy
1,563,158
+35,600
+2% +$1.71M 0.33% 49
2025
Q3
$68.9M Buy
1,527,558
+94,500
+7% +$4.41M 0.27% 63
2025
Q2
$66.3M Buy
1,433,058
+87,600
+7% +$4.3M 0.29% 62
2025
Q1
$82.1M Buy
1,345,458
+59,700
+5% +$3.48M 0.4% 37
2024
Q4
$72.7M Buy
+1,285,758
New +$71.8M 0.34% 43

Other funds holding BMY

KLP Kapitalforvaltning's BMY Position: Q1 2026 in Review

KLP Kapitalforvaltning increased its Bristol-Myers Squibb (BMY) stake by 1.8% in Q1 2026, buying an estimated $1.66M and bringing the position to 1,591,658 shares worth $96.5M. The position accounts for 0.38% of the portfolio, ranked #42.

KLP Kapitalforvaltning first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • KLP Kapitalforvaltning held 1,591,658 shares of Bristol-Myers Squibb worth $96.5M as of Q1 2026.
  • KLP Kapitalforvaltning bought 28,500 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.66M.
  • Bristol-Myers Squibb made up 0.38% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #42 holding.
  • KLP Kapitalforvaltning first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.